← Human Trials & Peer-Reviewed Studies

Magnesium status and supplementation influence vitamin D status and metabolism: results from a randomized trial.

Plain-language guide to PMID 30541089 (2018): double-blind randomized controlled trial of Vitamin D, K2, Magnesium and Zinc in 180 participants.

Key Facts

PMID
30541089
Journal
The American journal of clinical nutrition
Year
2018
Study type
Randomized Controlled Trial
Authors
Dai Q et al. (15 authors)
DOI
10.1093/ajcn/nqy274
Registered trial
NCT03265483

What This Study Did, in Plain Language

What Was Tested

The paper reports a study of Vitamin D, K2, Magnesium and Zinc, published as a randomized controlled trial.

The aim of this study was to test the hypothesis that magnesium supplementation differentially affects vitamin D metabolism dependent on baseline 25-hydroxyvitamin D [25(OH)D] concentration.

Why It Was Studied

Previous in vitro and in vivo studies indicate that enzymes that synthesize and metabolize vitamin D are magnesium dependent.

Who Took Part

The study group was 180 participants.

PubMed indexes the participants as middle-aged adults and older adults, both men and women.

Subjects were randomly assigned to treatments using a permuted-block randomization algorithm.

How the Study Was Run

The researchers set it up as a randomized, double-blind and placebo-controlled study.

The participants were allocated by chance, so the Vitamin D, K2, Magnesium and Zinc group and the comparison group should start out alike.

As a double-blind Vitamin D, K2, Magnesium and Zinc study, the assignments were hidden from both participants and investigators until the end.

A placebo (an inactive look-alike) gave the Vitamin D, K2, Magnesium and Zinc group a baseline to be compared against.

The PPCCT is a double-blind 2 × 2 factorial randomized controlled trial conducted in the Vanderbilt University Medical Center.

Changes in plasma 25-hydroxyvitamin D3 [25(OH)D3], 25-hydroxyvitamin D2 [25(OH)D2], 1,25-dihydroxyvitamin D3, 1,25-dihydroxyvitamin D2, and 24,25-dihydroxyvitamin D3 [24,25(OH)2D3] were measured by liquid chromatography-mass spectrometry.

What Was Measured

PubMed files the paper under topics including 24,25-Dihydroxyvitamin D 3, 25-Hydroxyvitamin D 2, Calcifediol, Calcitriol, Dietary Supplements, Ergocalciferols and Kidney.

What This Means in Plain Language

The paper is a randomized, double-blind and placebo-controlled study of Vitamin D, K2, Magnesium and Zinc in 180 participants.

Results are reported in around 6 sentences of the abstract; we leave them to the paper itself rather than summarise them.

The publication is from 2018 (The American journal of clinical nutrition), a journal based in United States.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.

Our Notes on the Compound

Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.

Related Pages

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.